Regional Associations
Pharma Deutschland has created a regional association structure. To this end, the association has joined the VCI (German Chemical Industry Association) and uses its structure.
This is how Pharma Deutschland will strengthen the industry's presence at the regional level. In close cooperation with the VCI, the regional associations enable efficient representation of interests at regional and national level. They thus make a significant contribution to strengthening Pharma Deutschland.
The introduction of the regional associations also brings Pharma Deutschland closer to its members. In turn, networking with stakeholders from the healthcare sector should serve to improve the supply of medicines at regional and local level.
In order to achieve all of this, efficient regional association structures are to be created in both honorary and full-time positions. Interesting discussion and event formats in the regions are also planned.
Official founding of the national associations and onboarding of member companies
From mid-June to mid-July 2024, the six individual national associations will be officially founded. During this important phase, our member companies will also undergo onboarding at the offices of the national associations.
This process marks a significant milestone in our organizational structure and ensures that all member companies are optimally prepared for their new tasks and have the resources they need to get off to a successful start.
Added value of the regional associations for member companies
- more direct access to politics at state and federal level
- better visibility of companies through greater involvement at state level
- pooling of interests through regionalization
- stronger presence and visibility of the industry in the region through regional public relations and press work
- greater identification with the association through regional contacts
- stronger networking among each other
- creating forums to become more involved in the association's work
- better communication of Pharma Deutschland's work at European level and in federal politics